Key Highlights
● NOC closed at $480.72 on 9 October 2026.
● The second data set consensus target is $623, implying about 29.6% upside.
● The analyst rating consensus is Buy.
● TD Cowen lowered its target from $590 to $540 on 9 October.
Northrop Grumman (NYSE:NOC), a member of the S&P 500, ended Friday 9 October 2026 at $480.72. Analyst targets sit well above that level, with the consensus implying upside of about 29.6%, and ratings lean positive. Recent broker revisions have mostly been downward.
What Is the Latest Analyst Price Target?
The second data set, using third-party data, shows an average price target of $623 from 26 analysts and a median of $613.50. Against the $480.72 close, the average implies upside of about 29.6%. Targets range from $419 to $815.
Market data reports a higher average of $644.70 from 25 analysts. Named broker targets published since mid-July average closer to $600, and several were cut in October, so the second data set figure has been used as the more current reference.
What Are Wall Street Analysts Saying?
Sentiment is positive on balance but has become more divided. The second data set counts 11 Strong Buy, three Buy, 11 Hold and one Sell rating, and labels the consensus Buy. Market data records one Strong Buy, 14 Buy, nine Hold and one Sell.
October has brought several changes. TD Cowen lowered its Hold-rated target from $590 to $540 on 9 October. Barclays initiated coverage on 8 October with an Underweight rating and a $419 target, the lowest on the Street. Rothschild & Co Redburn initiated with a Buy and a $680 target on 6 October, and BNP Paribas Exane cut its Outperform target from $640 to $540 the same day. Royal Bank of Canada downgraded the shares to Sector Perform on 2 October and lowered its target from $640 to $525. Citigroup (Buy, $667) and Susquehanna (Buy, $655) maintained positive views.
Earlier, UBS raised its Buy target from $685 to $704 on 8 September.
What Could Help the Stock Reach the Price Target?
Market data reports latest-quarter earnings per share of $7.68 against a consensus of $6.82, and notes that the company raised full-year 2026 earnings-per-share guidance to a range of $28.60 to $29.10, compared with a consensus of $27.95. Continued execution against that guidance would support the bullish case.
The shares trade at a considerable discount to the average target, so any recovery in sentiment towards defence stocks, or reassurance on programme performance and margins, could narrow the gap. Several brokers, including UBS, Citigroup and Rothschild & Co Redburn, retain targets well above the current price.
What Could Prevent the Stock Reaching the Target?
The latest wave of target cuts and the RBC downgrade show analysts becoming more cautious, and Barclays' Underweight view is a clear dissent.
Defence companies can be affected by programme timing, cost overruns on fixed-price contracts and government budget decisions. If further brokers cut their targets, the consensus could drift lower. A share price near its 52-week low also indicates that investors are currently unconvinced by the upside case.
What Should Investors Watch Next?
Investors may wish to watch whether the company confirms its raised full-year guidance, government budget developments, and whether broker revisions continue to be negative or begin to stabilise.
The Analyst Case for Northrop Grumman, in Numbers
Northrop Grumman closed at $480.72 on 9 October 2026, against a second data set consensus target of $623. TD Cowen lowered its Hold-rated target from $590 to $540 on 9 October.






Please wait processing your request...